Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

New cancer drugs often cause skin and nail problems.

Targeting specific T cells may help treat alopecia areata.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Alopecia areata involves unique activation of certain immune cells.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

A patient with lupus experienced a condition where their immune cells became overactive.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Upadacitinib effectively treats pyoderma gangrenosum.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.